Current Neuro-Oncology

Volume 26 Number 27
30 November 2024

Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 27, 30 November

Kesari S, Wojcinski A, Pabla S, Seager RJ, Gill JM, Carrillo JA, Wagle N, Park DJ, Nguyen M, Truong J, Takasumi Y, Chaiken L, Chang SC, Barkhoudarian G, Kelly DF, Juarez TM.
Pre-radiation Nivolumab plus ipilimumab in patients with newly diagnosed high-grade gliomas.
Oncoimmunology. 2024 Nov 21;13(1):2432728. doi: 10.1080/2162402X.2024.2432728. PMID: 39572979. Interventional study. ˍ

Mendez JS, Cohen AL, Eckenstein M, Jensen RL, Burt LM, Salzman KL, Chamberlain M, Hsu HH, Hutchinson M, Iwamoto F, Ligon KL, Mrugala MM, Pelayo M, Plotkin SR, Puduvalli VK, Raizer J, Reardon DA, Sterba M, Walbert T, West BL, Wong ET, Zhang C, Colman H.
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
Neurooncol Adv. 2024 Nov 22;6(1):vdae202. doi: 10.1093/noajnl/vdae202. PMID: 39734810. Interventional study. ˍ

Aljaafary M, Alali AA.
Association of imaging biomarkers with molecular subtypes of medulloblastoma.
Neuroradiol J. 2024 Nov 25:19714009241303065. doi: 10.1177/19714009241303065. PMID: 39586576. Observational study. ˍ

Mitchell M, Restrepo-Orozco A, Verhey LH, Vitaz T.
Long-term survival in a patient with Li-Fraumeni syndrome-associated giant cell glioblastoma treated with nivolumab: illustrative case.
J Neurosurg Case Lessons. 2024 Nov 25;8(22):CASE24539. doi: 10.3171/CASE24539. PMID: 39586078. Case report. ˍ

Chan SC, Chiu TL, Ng SH, Kao HW, Tsai ST, Liu SH.
¹⁸F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study.
Ann Nucl Med. 2024 Nov 26. doi: 10.1007/s12149-024-02005-4. PMID: 39589672. Interventional study˰ ˍ

Deshpande S, Nayal B, Nair R, Nayak D, J P, V G.
Role of h3k27me3 and ki67 labelling index in assessing the biological behaviour of meningiomas.
World Neurosurg. 2024 Nov 26:S1878-8750(24)01959-4? doi: 10.1016/j.wneu.2024.11.097? PMID: 39608490. Laboratory investigation˰ ˍ

Lee D, Lee E, Roh TH, Kim SH.
Optimal timing of chemoradiation after resection or biopsy of glioblastomas: a nationwide population-based study.
BMC Cancer. 2024 Nov 26;24(1):1450. doi: 10.1186/s12885-024-13223-4. PMID: 39587516. Observational study. ˍ

Lu W, Feng J, Zou Y, Liu Y, Gao P, Zhao Y, Wu X, Ma H.
1H-MRS parameters in non-enhancing peritumoral regions can predict the recurrence of glioblastoma.
Sci Rep. 2024 Nov 26;14(1):29258. doi: 10.1038/s41598-024-80610-z. PMID: 39587278. Observational study. ˍ

Rogers S, Gross M, Ermis E, Cosgun G, Baumert BG, Mader T, Schroeder C, Lomax N, Alonso S, Ademaj A, Lazeroms T, Lee SY, Mayinger M, Mamot C, Schwyzer L, Schubert GA, Riesterer O.
Re-irradiation for recurrent glioblastoma: a pattern of care analysis.
BMC Neurol. 2024 Nov 26;24(1):462. doi: 10.1186/s12883-024-03954-z. PMID: 39587462. Observational study. ˍ

Garcia DG, Casas MÁG, Martínez MHG.
Gliomatosis Cerebri Manifested as Parkinsonism Syndrome: A Case Report.
Case Rep Neurol Med. 2024 Nov 28;2024:3375867. doi: 10.1155/crnm/3375867. PMID: 39641121. Case report. ˍ

*Kanamori M, Tsuzuki S, Shibahara I, Saito K, Shimoda Y, Tanaka K, Yamaguchi S, Natsumeda M, Matsutani T, Hanihara M, Nakada M, Kuroda JI, Matsuda M, Yoshimoto K, Yonezawa U, Sonoda Y, Takano K, Yonezawa H, Otani Y, Nakahara Y, Uchida M, Nonaka M, Mineharu Y, Kitamura Y, Yamashita S, Yamauchi T, Miyake Y, Deguchi S, Beppu T, Tamura K, Koizumi S, Hirose Y, Asano K, Hiruta R, Kinoshita M, Miyake K, Nakayama N, Inoue A, Ono T, Sasaki T, Akiyama Y, Fukami S, Yoshino A, Kawanishi Y, Asanome T, Yamaguchi T, Takahashi M, Yamasaki F, Arakawa Y, Narita Y.
Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort study.
Neurooncol Adv. 2024 Nov 28;6(1):vdae176. doi: 10.1093/noajnl/vdae176. PMID: 39659832. Observational study. ˍ

Panetta JC, Selvo NS, Mater DV, Stewart CF.
Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors.
Pharmaceutics. 2024 Nov 28;16(12):1528. doi: 10.3390/pharmaceutics16121528. PMID: 39771507. Interventional study. ˍ

Qiu Y, Li Y, Cuihong J, Wu X, Liu W, Fan C, Ye X, He L, Xiao S, Zhao Q, Wu W, Chen K, Tan C, Li Y, Wang H, Liu F.
Toxicity and Efficacy of Different Target Volume Delineations of Radiotherapy Based on the Updated RTOG/NRG and EORTC Guidelines in Patients with Grade 3-4 Glioma: A Randomized Controlled Clinical Trial.
Int J Radiat Oncol Biol Phys. 2024 Nov 28:S0360-3016(24)03668-X. doi: 10.1016/j.ijrobp.2024.11.094. PMID: 39615657. Interventional study˰ ˍ

Mattey LR, James Z, Lilo T, El Adwan Y, Scala MR, Kamaly-Asl I, Mallucci C, Leach P.
Paediatric meningiomas: a multi-centre case series of 27 patients.
Childs Nerv Syst. 2024 Nov 29;41(1):13. doi: 10.1007/s00381-024-06684-2. PMID: 39612013. Observational study. ˍ

Wang Y, Sun L, Di G, Jiang X.
Post-traumatic glioma: Report of one case.
Asian J Surg. 2024 Nov 29:S1015-9584(24)02742-8. doi: 10.1016/j.asjsur.2024.11.116. PMID: 39616052. Case report. ˍ

Xiao W, Li S, Tong Z, Li L, Zhang Y.
The Value of Diffusion Tensor Imaging in Differential Diagnosis of Embryonal Tumors Occurring in the Brainstem and Brainstem Gliomas in Pediatric Patients.
Pediatr Neurol. 2024 Nov 29;163:58-65. doi: 10.1016/j.pediatrneurol.2024.11.011. PMID: 39689574. Observational study˰ ˍ